Deal date

KANDO id: 14396347

Financial Transaction:

Acquisition


King Pharmaceuticals


Currency
United States Dollar
Value in original currency
3,600,000,000
Company valuation (pre money)
3,600,000,000
Value in USD
3,600,000,000
Company valuation in USD (pre money)
3,600,000,000

Lead investor

Country Notes

Pfizer Inc

 United States USD 3,600,000,000 (USD 3,600,000,000) Initial investment.